Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H20O2 |
Molecular Weight | 220.3074 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C(O)=O)C1=CC=C(CC(C)C)C=C1
InChI
InChIKey=UULSXYSSHHRCQK-UHFFFAOYSA-N
InChI=1S/C14H20O2/c1-4-13(14(15)16)12-7-5-11(6-8-12)9-10(2)3/h5-8,10,13H,4,9H2,1-3H3,(H,15,16)
Molecular Formula | C14H20O2 |
Molecular Weight | 220.3074 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Butibufen is a non-steroidal anti-inflammatory cyclooxygenase inhibitor with analgesic and antipyretic properties. The drug was investigated for the treatment of osteoarthritis, rheumatoid artritis, and other arthroses. It was marketed under tradenames Mijal and Butilopan but now is withdrawn from the market.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10579692 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:06:20 GMT 2023
by
admin
on
Sat Dec 16 17:06:20 GMT 2023
|
Record UNII |
JSS1TEM917
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000088627
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
DTXSID20102160
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
SUB06015MIG
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
447
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
55837-18-8
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
m2799
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
JSS1TEM917
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
CHEMBL454450
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
C73083
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
19880
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | RxNorm | ||
|
41643
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
C012797
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
3657
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY | |||
|
259-849-2
Created by
admin on Sat Dec 16 17:06:20 GMT 2023 , Edited by admin on Sat Dec 16 17:06:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |